Cancer biomarkers circulating in body fluids can be used for diagnosis and treatment monitoring. However, current detection technology lacks the required sensitivity, limiting biomarker use in clinical applications.
Colorectal cancer is the second most common cancer in Europe with respect to incidence and mortality. Although early detection significantly improves outcome, screening compliance in the wider population is low due to the invasive nature of the colonoscopy procedure.
To facilitate prompt cancer diagnosis, the EU-funded ULTRAPLACAD project developed an in vitro platform for the detection of cancer nucleic acid and protein biomarkers circulating in the blood. “The idea was to improve biomarker detection sensitivity by a factor of 1 000, reduce the cost four-fold and the analysis time down to 1 hour,″ explains project coordinator Prof. Giuseppe Spoto of the University of Catania in Italy. The project team involved 13 partners across Europe with cross-disciplinary competencies, including pioneers in surface plasmon resonance.
Innovative technologies
The ULTRAPLACAD device has been designed to integrate a microfluidic circuit with functionalised nanostructure chips. It combines nanostructure-enhanced surface plasmon resonance imaging (NESPRI) and plasmon-enhanced fluorescence spectroscopy imaging (PEFSI). These two novel sensing technologies provide ultrasensitive detection and reduce the need for sample chemical modifications.
Chip design, surface architecture and chemical functionalisation of nanostructures facilitate the simultaneous measurement of multiple markers. For efficient nucleic acid detection, such as Ras mutations and miRNAs, specific probes have been synthesised. The disposable chips are mass produced through an automated fabrication process, which brings down the cost of the assay.
Traditionally, detection of minute amounts of DNA released in body fluids by tumour cells necessitates a pre-amplification step by polymerase chain reaction. The novelty of ULTRAPLACAD lies in the detection assays that do not require enzymatic amplification of DNA in liquid biopsies, thereby avoiding potential errors.
A bimodal reader for NESPRI and PEFSI technologies makes the ULTRAPLACAD device unique and improves the overall detection process even further. As Dr Spoto emphasises “the main advantage of the device is that it can detect both nucleic acids and protein using one single equipment operating with disposable chips.″
The ULTRAPLACAD prototype has been validated using animal models and samples from colorectal cancer patients. Results demonstrate that the sensitivity of the device exceeds conventional detection platforms and the whole assay is faster and simpler in its implementation.
The future of ULTRAPLACAD
Undoubtedly, the combined detection of cancer DNA sequences and selected tumour autoantibodies provide an effective cancer detection approach. ULTRAPLACAD offers a unique platform that can detect both DNA and protein cancer biomarkers, simplifying the process of diagnosis and patient follow-up.
Considering the limitations of existing colorectal cancer screening choices, ULTRAPLACAD offers a non-invasive alternative solution for average-risk asymptomatic people. As such, it will reduce the number of invasive procedures, cut down healthcare costs, and improve patient compliance and management.
Although the platform was specifically fabricated for early diagnosis and prognosis of colorectal cancer, its application can extend to other types of cancer. Long-term, it is also expected to determine the molecular heterogeneity of individual tumours, helping disease stratification and personalised therapy. In view of the future, Prof. Spoto envisages “the ULTRAPLACAD device will contribute to revolutionise molecular diagnosis of cancer and make a difference in cancer care.″
News
Lipid nanoparticles discovered that can deliver mRNA directly into heart muscle cells
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC Berkeley-led [...]
The basic mechanisms of visual attention emerged over 500 million years ago, study suggests
The brain does not need its sophisticated cortex to interpret the visual world. A new study published in PLOS Biology demonstrates that a much older structure, the superior colliculus, contains the necessary circuitry to perform the [...]
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
Self-Organizing Light Could Transform Computing and Communications
USC engineers have demonstrated a new kind of optical device that lets light organize its own route using the principles of thermodynamics. Instead of relying on switches or digital control, the light finds its own [...]
